CAC Nantong Chemical Co., Ltd. (SHE:301665)
China · Delayed Price · Currency is CNY 29.46
+0.54 (1.87%)
Feb 6, 2026, 3:04 PM CST
CAC Nantong Chemical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 5,082 | 4,215 | 3,821 | 5,078 | 3,572 | 3,052 |
Other Revenue | 21.56 | 21.56 | 47.69 | 20.66 | 7.15 | 6.47 |
| 5,103 | 4,236 | 3,868 | 5,099 | 3,579 | 3,058 | |
Revenue Growth (YoY) | 30.73% | 9.51% | -24.14% | 42.47% | 17.03% | -1.50% |
Cost of Revenue | 3,744 | 3,348 | 2,953 | 3,740 | 2,671 | 2,103 |
Gross Profit | 1,360 | 887.97 | 915.36 | 1,359 | 907.79 | 954.97 |
Selling, General & Admin | 402.58 | 317.28 | 295.65 | 297.87 | 230.83 | 213.26 |
Research & Development | 178.32 | 144.04 | 145.91 | 179.14 | 118.41 | 105.93 |
Other Operating Expenses | 17.78 | 16.02 | 16.33 | 15.07 | 14.46 | 12.79 |
Operating Expenses | 606.25 | 502.4 | 451.14 | 502.81 | 371.64 | 335.85 |
Operating Income | 753.59 | 385.57 | 464.21 | 856.19 | 536.14 | 619.12 |
Interest Expense | -68.86 | -65.82 | -62.23 | -63.81 | -39.64 | -38.93 |
Interest & Investment Income | 2.19 | 2.03 | 4.32 | 2.93 | 11.57 | 4.45 |
Currency Exchange Gain (Loss) | 21.38 | 21.38 | 22.56 | 50.48 | -18.82 | -24.81 |
Other Non Operating Income (Expenses) | 1.53 | -3.95 | -2.81 | -4.46 | -3.56 | -4.29 |
EBT Excluding Unusual Items | 709.84 | 339.21 | 426.05 | 841.32 | 485.69 | 555.54 |
Gain (Loss) on Sale of Investments | -4.11 | -7.59 | -16.95 | -40.27 | 1.23 | 0.31 |
Gain (Loss) on Sale of Assets | -2.52 | -0.92 | -1.8 | -7.15 | -4.01 | -3.64 |
Asset Writedown | 5.62 | - | - | -12.77 | - | - |
Other Unusual Items | -11.82 | -7.13 | -25.7 | -11.65 | -0.47 | 56.65 |
Pretax Income | 697.02 | 323.56 | 381.6 | 769.48 | 482.45 | 608.85 |
Income Tax Expense | 105.07 | 32.81 | 43.81 | 107.93 | 51.73 | 84.66 |
Earnings From Continuing Operations | 591.95 | 290.75 | 337.79 | 661.55 | 430.72 | 524.19 |
Minority Interest in Earnings | -125.15 | -24.81 | 8.68 | -12.43 | -32.78 | -130.88 |
Net Income | 466.8 | 265.94 | 346.48 | 649.13 | 397.93 | 393.31 |
Net Income to Common | 466.8 | 265.94 | 346.48 | 649.13 | 397.93 | 393.31 |
Net Income Growth | 121.08% | -23.24% | -46.62% | 63.12% | 1.18% | -25.75% |
Shares Outstanding (Basic) | 422 | 403 | 403 | 406 | 406 | 405 |
Shares Outstanding (Diluted) | 422 | 403 | 403 | 406 | 406 | 405 |
Shares Change (YoY) | 4.13% | 0.01% | -0.70% | -0.09% | 0.14% | 0.28% |
EPS (Basic) | 1.11 | 0.66 | 0.86 | 1.60 | 0.98 | 0.97 |
EPS (Diluted) | 1.11 | 0.66 | 0.86 | 1.60 | 0.98 | 0.97 |
EPS Growth | 112.32% | -23.26% | -46.25% | 63.27% | 1.03% | -25.95% |
Free Cash Flow | -183.96 | -575.49 | -225.69 | -134.1 | -393.79 | 186.13 |
Free Cash Flow Per Share | -0.44 | -1.43 | -0.56 | -0.33 | -0.97 | 0.46 |
Dividend Per Share | 0.600 | 0.400 | - | - | 0.750 | - |
Gross Margin | 26.65% | 20.96% | 23.66% | 26.65% | 25.36% | 31.23% |
Operating Margin | 14.77% | 9.10% | 12.00% | 16.79% | 14.98% | 20.24% |
Profit Margin | 9.15% | 6.28% | 8.96% | 12.73% | 11.12% | 12.86% |
Free Cash Flow Margin | -3.60% | -13.58% | -5.83% | -2.63% | -11.00% | 6.09% |
EBITDA | 1,006 | 624.72 | 686.23 | 1,057 | 696.46 | 762.83 |
EBITDA Margin | 19.70% | 14.75% | 17.74% | 20.72% | 19.46% | 24.94% |
D&A For EBITDA | 252 | 239.15 | 222.02 | 200.59 | 160.32 | 143.7 |
EBIT | 753.59 | 385.57 | 464.21 | 856.19 | 536.14 | 619.12 |
EBIT Margin | 14.77% | 9.10% | 12.00% | 16.79% | 14.98% | 20.24% |
Effective Tax Rate | 15.07% | 10.14% | 11.48% | 14.03% | 10.72% | 13.91% |
Revenue as Reported | 5,103 | 4,236 | 3,868 | - | - | - |
Advertising Expenses | - | 7.36 | 7.2 | 2.62 | 2.72 | 3.27 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.